| 2026 |
Collins, K., Donnellan, L., Asif, Z., Chan, N. S. L., Subramaniam, S., Kamath, S., . . . Joyce, P. (2026). The gut microbiome modulates the lipase-mediated digestion of dietary lipid emulsions. Colloids and Surfaces B Biointerfaces, 265, 14 pages.
DOI |
| 2026 |
Khetan, R., Donnellan, L., Collins, K., Kamath, S., Ariaee, A., Rajapaksha, W., . . . Joyce, P. (2026). The gut microbiota regulates the protein corona formation, biodistribution, and cellular uptake of lipid nanoparticles. Journal of Controlled Release, 395, 15 pages.
DOI |
| 2025 |
Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N., Clark, S. R., . . . Joyce, P. (2025). IUPHAR Themed Review: The Gut Microbiome in Schizophrenia.. Pharmacological Research, 211(107561), 107561-1-107561-13.
DOI Scopus19 WoS17 Europe PMC14 |
| 2025 |
Kamath, S., Ariaee, A., Abdelhafez, A., Asif, Z., Chan, N. S. L., Collins, K., . . . Joyce, P. (2025). Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release. Advanced Drug Delivery Reviews, 227(115720), 1-23.
DOI Scopus8 WoS7 Europe PMC5 |
| 2024 |
Kamath, S., Hunter, A., Collins, K., Wignall, A., & Joyce, P. (2024). The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats. British Journal of Pharmacology, 181(22), 4531-4545.
DOI Scopus18 WoS18 Europe PMC14 |
